-
-
-
-
-
-
-
Celldex Therapeutics (CLDX) PT Lowered to $42 at H.C. Wainwright
-
-
-
-
-
-
-
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating, $73 Price Target on Celldex Therapeutics (CLDX)
-
-
-
-
-
-
-
Celldex Therapeutics (CLDX) PT Raised to $50 at H.C. Wainwright
-
-
-
-
-
-
-
Celldex Therapeutics Announces Pricing of $130.4 Million Public Offering of Common Stock
-
-
-
-
-
-
21,369 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

